Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ohe

Showing results (121-130 of 191) with videos related to

Pageof 20
Sort By:
Japanese Journal of Cancer Research : Gann|November 1, 1994
A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatinH Ohmatsu, K Eguchi, T Shinkai, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ functionN Yamamoto, T Tamura, M Maeda, et al.
Japanese Journal of Cancer Research : Gann|October 1, 1994
Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusionT Tamura, Y Sasaki, K Eguchi, et al.
Cancer Research|August 1, 1989
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell linesY Ohe, K Nakagawa, Y Fujiwara, et al.
ESMO Open|July 30, 2023
Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastasesK Tamura, T Yoshida, K Masuda, et al.
American Journal of Clinical Oncology|October 1, 1994
A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patientsA Kojima, T Shinkai, Y Soejima, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Comparative study of the antitumor effect of two types of murine recombinant interferons, (beta) and (gamma), against B16-F10 melanomaM Sakurai, M Iigo, T Tamura, et al.
International Journal of Cancer|July 31, 2001
Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosisJ Usuda, T Okunaka, K Furukawa, et al.
Japanese Journal of Clinical Oncology|November 30, 2000
Bacterial meningitis observed in a phase I trial of vinorelbine, cisplatin and thoracic radiotherapy for non-small cell lung cancer: report of a case and discussion on dose-limiting toxicityI Sekine, T Matsuda, T Saisho, et al.
Transfusion|August 1, 1995
Anti-A and/or anti-B is not detectable in some patients who underwent ABO-incompatible bone marrow transplantationK Maeda, K Taniwaki, T Santo, et al.
Pageof 20

Showing results (121-130 of 191) with videos related to

Sort By:
Pageof 20
Japanese Journal of Cancer Research : Gann|November 1, 1994
A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatinH Ohmatsu, K Eguchi, T Shinkai, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ functionN Yamamoto, T Tamura, M Maeda, et al.
Japanese Journal of Cancer Research : Gann|October 1, 1994
Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusionT Tamura, Y Sasaki, K Eguchi, et al.
Cancer Research|August 1, 1989
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell linesY Ohe, K Nakagawa, Y Fujiwara, et al.
ESMO Open|July 30, 2023
Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastasesK Tamura, T Yoshida, K Masuda, et al.
American Journal of Clinical Oncology|October 1, 1994
A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patientsA Kojima, T Shinkai, Y Soejima, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Comparative study of the antitumor effect of two types of murine recombinant interferons, (beta) and (gamma), against B16-F10 melanomaM Sakurai, M Iigo, T Tamura, et al.
International Journal of Cancer|July 31, 2001
Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosisJ Usuda, T Okunaka, K Furukawa, et al.
Japanese Journal of Clinical Oncology|November 30, 2000
Bacterial meningitis observed in a phase I trial of vinorelbine, cisplatin and thoracic radiotherapy for non-small cell lung cancer: report of a case and discussion on dose-limiting toxicityI Sekine, T Matsuda, T Saisho, et al.
Transfusion|August 1, 1995
Anti-A and/or anti-B is not detectable in some patients who underwent ABO-incompatible bone marrow transplantationK Maeda, K Taniwaki, T Santo, et al.
Pageof 20